Target intelligence / Profile preview

Cutaneous sensory nociceptor

Molecular classification
Other
01

Overview

Cutaneous sensory nociceptors are specialized primary afferent neurons that terminate in the skin and are responsible for detecting potentially damaging stimuli, such as extreme temperature, mechanical pressure, or chemical irritants [Dubin & Patapoutian, 2010]. These neurons convert noxious stimuli into electrical signals that are transmitted to the central nervous system, ultimately resulting in the perception of pain [Basbaum et al., 2009]. While they are essential for protective reflexes and avoiding injury, their sensitization or dysfunction plays a central role in chronic and neuropathic pain conditions [Gold & Gebhart, 2010]. Pharmacological interventions often target specific ion channels and receptors expressed on these fibers, such as voltage-gated sodium channels (e.g., Nav1.7, Nav1.8) and transient receptor potential (TRP) channels (e.g., TRPV1), to modulate pain signaling [Wood et al., 2004]. Because cutaneous sensory nociceptors refers to a heterogeneous population of cells rather than a single protein, it is considered a physiological system rather than a discrete molecular target [StatPearls, 2023]. Consequently, drugs interacting with these nociceptors typically act on the various receptors and channels embedded within their membranes to achieve analgesic effects [Anand & Bley, 2011].

Other names
Nociceptive primary afferentPain-sensing nerve fiberCutaneous nociceptorSmall-diameter sensory neuronA-delta fiber nociceptorC-fiber nociceptor
02

Mechanism of action

Modulation of ion channel activity, including voltage-gated sodium channel blockade and TRP channel activation or desensitization, to inhibit the generation and conduction of nociceptive signals [Anand & Bley, 2011; Wood et al., 2004].

03

Biological functions

Signal transductionNociceptionSomatosensationThermoreceptionChemoreception
04

Disease associations

InflammationNeuropathic painChronic painPruritus (itch)AllodyniaHyperalgesia
05

Safety considerations

Loss of protective sensationNumbnessPotential for neurotoxicityLocal skin irritationRisk of unnoticed tissue damage
06

Interacting drugs

Lidocaine

6 more in the full profile.

07

Biomarkers

Intraepidermal nerve fiber density (IENFD) [Anand & Bley, 2011]Quantitative sensory testing (QST) [StatPearls, 2023]Protein gene product 9.5 (PGP9.5) expression [Dubin & Patapoutian, 2010]C-fiber conduction velocity [Nature Reviews Neuroscience, 2003]

Beyond the preview

Go deeper on Cutaneous sensory nociceptor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cutaneous sensory nociceptor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call